Federalist

Share

Federalist

 •  October 19, 2017

Lost in the country’s inevitable descent into single-payer health care is the role the federal government plays in the skyrocketing prices of both over-the-counter (OTC) and prescription medications. While the rising premiums, increasing out of pocket costs, and deteriorating quality of service resulting from Obamacare are the direct consequence of...

Federalist

 •  May 17, 2017

A recent flurry of activity hints the Trump administration may be moving from a populist platform of lowering prescription drug costs by “cutting better deals” and importing drugs from Canada to economically sound market-based reforms. Health and Human Services Secretary Tom Price, Trump’s pick to lead the administration’s efforts to lower drug...

Federalist

 •  April 6, 2017

As a pharmacist and pharmacologist, I have followed the Food and Drug Administration and its policy decisions for almost two decades. Some of the time I have done it from inside the agency, as a medical officer and senior medical analyst. Other times, I’ve watched from the outside as a Yale University professor of pharmacology and investigational...